eFFECTOR Therapeutics, Inc. Earnings Per Share (Diluted)
eFFECTOR Therapeutics, Inc. reported Earnings Per Share (Diluted) of -$2.16 per share for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2024-05-09
- eFFECTOR Therapeutics, Inc. earnings per share, diluted for the quarter ending 2024-03-31 was -$2.16.
- eFFECTOR Therapeutics, Inc. earnings per share, diluted for the quarter ending 2023-09-30 was -$0.13.
- eFFECTOR Therapeutics, Inc. earnings per share, diluted for the quarter ending 2023-06-30 was -$0.17.
- eFFECTOR Therapeutics, Inc. earnings per share, diluted for the quarter ending 2023-03-31 was -$5.96, a 8614.29% decline year-over-year.
- eFFECTOR Therapeutics, Inc. earnings per share, diluted for fiscal 2023 was -$16.37.
- eFFECTOR Therapeutics, Inc. earnings per share, diluted for fiscal 2022 was -$13.76, a 3227.27% decline from fiscal 2021.
- eFFECTOR Therapeutics, Inc. earnings per share, diluted for fiscal 2021 was $0.44, a 300.00% increase from fiscal 2020.
- eFFECTOR Therapeutics, Inc. earnings per share, diluted for fiscal 2020 was $0.11.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-03-31 | -$2.16 10-Q · filed 2024-05-09 | ||||||
| 2023-12-31 | -$16.37 10-K · filed 2024-03-26 | ||||||
| 2023-09-30 | -$0.13 10-Q · filed 2023-11-13 | -$0.53 10-Q · filed 2023-11-13 | |||||
| 2023-06-30 | -$0.17 10-Q · filed 2023-08-08 | -$0.41 10-Q · filed 2023-08-08 | |||||
| 2023-03-31 | -$5.96 10-Q · filed 2024-05-09 | -$0.24 10-Q · filed 2023-05-09 | |||||
| 2022-12-31 | -$13.76 10-K · filed 2024-03-26 | -$0.55 10-K · filed 2023-03-08 | |||||
| 2022-09-30 | -$0.23 10-Q · filed 2023-11-13 | -$0.33 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | -$0.17 10-Q · filed 2023-08-08 | -$0.09 10-Q · filed 2023-08-08 | |||||
| 2022-03-31 | $0.07 10-Q · filed 2023-05-09 | ||||||
| 2021-12-31 | $0.15 derived: net income ÷ weighted average shares · filed 2023-03-08 | $0.38 derived: net income ÷ weighted average shares · filed 2023-03-08 | $0.45 derived: net income ÷ weighted average shares · filed 2023-03-08 | $0.44 10-K · filed 2023-03-08 | |||
| 2021-09-30 | $0.42 10-Q · filed 2022-11-07 | $0.28 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$0.49 10-Q · filed 2022-11-07 | ||||
| 2021-06-30 | -$3.83 10-Q · filed 2022-08-09 | -$0.37 8-K · filed 2021-08-31 | -$8.38 10-Q · filed 2022-08-09 | -$0.81 8-K · filed 2021-08-31 | |||
| 2021-03-31 | -$4.55 10-Q · filed 2022-05-10 | ||||||
| 2020-12-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2022-03-16 | -$3.65 derived: net income ÷ weighted average shares · filed 2022-03-16 | -$0.70 derived: net income ÷ weighted average shares · filed 2022-03-16 | $0.11 10-K · filed 2022-03-16 | |||
| 2020-09-30 | -$5.29 10-Q · filed 2021-11-08 | -$0.47 derived: net income ÷ weighted average shares · filed 2021-11-08 | $0.39 10-Q · filed 2021-11-08 | ||||
| 2020-06-30 | $0.02 8-K · filed 2021-08-31 | $0.07 8-K · filed 2021-08-31 |